These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15019562

  • 1. Pharmacological characterization of SIB-1663, a conformationally rigid analog of nicotine.
    Rao TS, Sacaan AI, Menzaghi FM, Reid RT, Adams PB, Correa LD, Whelan KT, Vernier JM.
    Brain Res; 2004 Apr 02; 1003(1-2):42-53. PubMed ID: 15019562
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.
    Sacaan AI, Reid RT, Santori EM, Adams P, Correa LD, Mahaffy LS, Bleicher L, Cosford ND, Stauderman KA, McDonald IA, Rao TS, Lloyd GK.
    J Pharmacol Exp Ther; 1997 Jan 02; 280(1):373-83. PubMed ID: 8996218
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of (S)-(2)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine HCl (SIB-1508Y, Altinicline), a novel nicotinic acetylcholine receptor agonist.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Cosford ND.
    Brain Res; 2008 Oct 09; 1234():16-24. PubMed ID: 18692487
    [Abstract] [Full Text] [Related]

  • 4. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Suto CM, Vernier JM.
    Brain Res; 2003 Aug 15; 981(1-2):85-98. PubMed ID: 12885429
    [Abstract] [Full Text] [Related]

  • 5. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats.
    Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):384-92. PubMed ID: 8996219
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological investigation of (+)- and (-)-cis-2,3,3a,4,5,9b-hexahydro-1-methyl-1H-pyrrolo-[3,2-h]isoq uinoline, a bridged-nicotine analog.
    Damaj MI, Glassco W, Marks MJ, Slobe B, James JR, May EL, Rosecrans JA, Collins AC, Martin BR.
    J Pharmacol Exp Ther; 1997 Sep 15; 282(3):1425-34. PubMed ID: 9316856
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.
    Reid RT, Lloyd GK, Rao TS.
    Br J Pharmacol; 1999 Jul 15; 127(6):1486-94. PubMed ID: 10455300
    [Abstract] [Full Text] [Related]

  • 8. Antinociceptive and pharmacological effects of metanicotine, a selective nicotinic agonist.
    Damaj MI, Glassco W, Aceto MD, Martin BR.
    J Pharmacol Exp Ther; 1999 Oct 15; 291(1):390-8. PubMed ID: 10490929
    [Abstract] [Full Text] [Related]

  • 9. Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine.
    Miller DK, Sumithran SP, Dwoskin LP.
    J Pharmacol Exp Ther; 2002 Sep 15; 302(3):1113-22. PubMed ID: 12183670
    [Abstract] [Full Text] [Related]

  • 10. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
    Wilkins LH, Grinevich VP, Ayers JT, Crooks PA, Dwoskin LP.
    J Pharmacol Exp Ther; 2003 Jan 15; 304(1):400-10. PubMed ID: 12490617
    [Abstract] [Full Text] [Related]

  • 11. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
    Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):310-8. PubMed ID: 7518514
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterization of recombinant human neuronal nicotinic acetylcholine receptors h alpha 2 beta 2, h alpha 2 beta 4, h alpha 3 beta 2, h alpha 3 beta 4, h alpha 4 beta 2, h alpha 4 beta 4 and h alpha 7 expressed in Xenopus oocytes.
    Chavez-Noriega LE, Crona JH, Washburn MS, Urrutia A, Elliott KJ, Johnson EC.
    J Pharmacol Exp Ther; 1997 Jan 15; 280(1):346-56. PubMed ID: 8996215
    [Abstract] [Full Text] [Related]

  • 13. In vitro regulation of serotonin transporter activity by protein kinase A and nicotinic acetylcholine receptors in the prefrontal cortex of rats.
    Awtry TL, Frank JG, Werling LL.
    Synapse; 2006 May 15; 59(6):342-9. PubMed ID: 16463401
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD, Williams KE.
    Neuropharmacology; 2007 Mar 15; 52(3):985-94. PubMed ID: 17157884
    [Abstract] [Full Text] [Related]

  • 15. Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors.
    Fu Y, Matta SG, James TJ, Sharp BM.
    J Pharmacol Exp Ther; 1998 Mar 15; 284(3):1188-96. PubMed ID: 9495882
    [Abstract] [Full Text] [Related]

  • 16. RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.
    Bencherif M, Lovette ME, Fowler KW, Arrington S, Reeves L, Caldwell WS, Lippiello PM.
    J Pharmacol Exp Ther; 1996 Dec 15; 279(3):1413-21. PubMed ID: 8968366
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS, Correa LD, Adams P, Santori EM, Sacaan AI.
    Brain Res; 2003 Nov 14; 990(1-2):203-8. PubMed ID: 14568345
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.
    Carroll FI, Hu X, Navarro HA, Deschamps J, Abdrakhmanova GR, Damaj MI, Martin BR.
    J Med Chem; 2006 Jun 01; 49(11):3244-50. PubMed ID: 16722642
    [Abstract] [Full Text] [Related]

  • 19. In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies.
    Rao TS, Reid RT, Correa LD, Santori EM, Gardner MF, Sacaan AI, Lorrain D, Vernier JM.
    Brain Res; 2003 Oct 03; 986(1-2):71-81. PubMed ID: 12965231
    [Abstract] [Full Text] [Related]

  • 20. Local alpha-bungarotoxin-sensitive nicotinic receptors modulate hippocampal norepinephrine release by systemic nicotine.
    Fu Y, Matta SG, Sharp BM.
    J Pharmacol Exp Ther; 1999 Apr 03; 289(1):133-9. PubMed ID: 10086996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.